Richard C. Rosenzweig - Mar 3, 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
EVP, Corp Dev, GC & Secretary
Signature
/s/ Lindi Barton-Brobst, Attorney-In-Fact for Richard C. Rosenzweig
Stock symbol
XRAY
Transactions as of
Mar 3, 2025
Transactions value $
-$124,914
Form type
4
Date filed
3/5/2025, 06:29 PM
Previous filing
Jan 14, 2025
Next filing
Mar 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XRAY Common Stock Award $0 +33.8K +59.35% $0.00 90.7K Mar 3, 2025 Direct F1
transaction XRAY Common Stock Tax liability -$23.2K -1.45K -1.6% $15.99 89.2K Mar 3, 2025 Direct F2
transaction XRAY Common Stock Tax liability -$79.2K -4.96K -5.55% $15.99 84.3K Mar 3, 2025 Direct F2
transaction XRAY Common Stock Tax liability -$22.4K -1.44K -1.71% $15.59 82.8K Mar 4, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Award $0 +350K $0.00 350K Mar 3, 2025 Common Stock 350K $15.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/3/2028.
F2 Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.
F3 Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2028.